Man Group plc - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 41 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Man Group plc ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q2 2023$1,387,403
-1.4%
2,211,0000.0%0.00%
-20.0%
Q1 2023$1,406,749
+55.7%
2,211,0000.0%0.01%
+66.7%
Q4 2022$903,746
-6.6%
2,211,0000.0%0.00%
-25.0%
Q3 2022$968,000
-3.7%
2,211,0000.0%0.00%0.0%
Q2 2022$1,005,000
+6.1%
2,211,000
+10.6%
0.00%
+33.3%
Q1 2022$947,0002,000,0000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Diameter Capital Partners LP 71,757,000$44,221,6864.15%
Context Capital Management, LLC 33,683$20,8461.88%
INHERENT GROUP, LP 9,000,000$5,587,1731.54%
BRAIDWELL LP 62,294,000$38,552,3281.26%
Aequim Alternative Investments LP 30,000,000$18,566,3120.70%
DeepCurrents Investment Group LLC 22,355,000$13,838,3720.55%
ABSOLUTE INVESTMENT ADVISERS, LLC 5,500,000$3,408,5920.48%
ARISTEIA CAPITAL, L.L.C. 30,280,000$18,739,5980.42%
Weiss Asset Management LP 4,500,000$2,773,2090.21%
Orbimed Advisors 15,000,000$9,265,3500.17%
View complete list of BRIDGEBIO PHARMA INC shareholders